<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35483416</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0003-4509</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Annales pharmaceutiques francaises</Title>
          <ISOAbbreviation>Ann Pharm Fr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Leptospirosis: a growing health threat to fish farming and recreational activities].</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">S0003-4509(22)00039-6</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pharma.2022.04.003</ELocationID>
        <Abstract>
          <AbstractText>Leptospirosis is a cosmopolitan infectious disease caused by the bacteria Leptospira interrogans, which is worldwide increasing as the result of climate changes favoring the reproduction of asymptomatic reservoir rodents, and also of flooding that brings mammals and humans into contact with contaminated water. This disease affects many mammals among wild, domestic or farmed animals. In humans, it is manifested by frustrated to severe forms that can lead to liver and kidney failure and death in about one in ten severe cases. Diagnostic methods and treatments are satisfactory. Prophylaxis is based on individual protective measures including vaccination. The single human vaccine that is available is expensive and it protects 97% against about a third of human pathogenic serovars. Moreover, this vaccine is not covered by health insurance. Better epidemiological knowledge, particularly at European level, could stimulate research in this area in order to obtain a vaccine that would protect more comprehensively against serovars pathogenic to humans.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Loiseau</LastName>
            <ForeName>Philippe M</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>Chimiothérapie antiparasitaire, ULR 8076 CNRS BioCIS, Faculté de Pharmacie de l'Université Paris-Saclay, France. Electronic address: philippe.loiseau@universite-paris-saclay.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>German</LastName>
            <ForeName>Michèle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Sciences biologiques appliquées à la Santé humaine, Académie nationale de Pharmacie, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>fre</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>La leptospirose : une menace sanitaire croissante pour les activités piscicoles et récréatives.</VernacularTitle>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>France</Country>
        <MedlineTA>Ann Pharm Fr</MedlineTA>
        <NlmUniqueID>2985176R</NlmUniqueID>
        <ISSNLinking>0003-4509</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Leptospirose</Keyword>
        <Keyword MajorTopicYN="N">Leptospirosis</Keyword>
        <Keyword MajorTopicYN="N">prophylaxie</Keyword>
        <Keyword MajorTopicYN="N">prophylaxis</Keyword>
        <Keyword MajorTopicYN="N">traitement</Keyword>
        <Keyword MajorTopicYN="N">treatments</Keyword>
        <Keyword MajorTopicYN="N">vaccines</Keyword>
        <Keyword MajorTopicYN="N">vaccins</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>19</Hour>
          <Minute>22</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35483416</ArticleId>
        <ArticleId IdType="doi">10.1016/j.pharma.2022.04.003</ArticleId>
        <ArticleId IdType="pii">S0003-4509(22)00039-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
